Effects of postmenopausal hormone replacement therapy on HbA(1c) levels.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Diabetes Care

• Publication date

  2003-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/DIACARE.26.4.1088PMID 12663578
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluating the effect of age on endometrial responsiveness to hormone replacement therapy: A histologic ultrasonographic, and tissue receptor analysis

  2005cited by this paper
• Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

  2002cited by this paper
• Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative Randomized Controlled Trial. Writing Group for the Women's Health Initiative Investigators. JAMA 2002; 288(3): 321-333

  2002cited by this paper
• Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women.

  2002cited by this paper
• The effect of estrogen use on levels of glucose and insulin and the risk of type 2 diabetes in american Indian postmenopausal women : the strong heart study.

  2002cited by this paper
• Hormone replacement therapy is associated with better glycemic control in women with type 2 diabetes: The Northern California Kaiser Permanente Diabetes Registry.

  2001cited by this paper
• Determinants of glycated haemoglobin in the general population: associations with diet, alcohol and cigarette smoking

  2001cited by this paper
• Conjugated equine estrogen improves glycemic control and blood lipoproteins in postmenopausal women with type 2 diabetes.

  2001cited by this paper
• Conjugated Equine Estrogen Improves Glycemic Control and Blood Lipoproteins in Postmenopausal Women With Type 2 Diabetes

  2001cited by this paper
• HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP).

  2001cited by this paper
• Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism.

  2001cited by this paper
• Cigarette smoking and glycaemia: the EPIC-Norfolk Study

  2001cited by this paper
• The impact of years since menopause on the development of impaired glucose tolerance.

  2001cited by this paper
• Cigarette smoking and glycaemia: the EPIC-Norfolk Study. European Prospective Investigation into Cancer.

  2001cited by this paper
• Predictive risk factors for deterioration from normoglycemic state to type 2 diabetes mellitus or impaired glucose tolerance in a Tunisian urban population.

  2001cited by this paper
• Cross-sectional study of determinants of menopausal age and hormone replacement therapy use in Italian women

  2000cited by this paper
• Postmenopausal Hormone Therapy Increases Risk for Venous Thromboembolic Disease: The Heart and Estrogen/progestin Replacement Study

  2000cited by this paper
• Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population.

  2000cited by this paper
• C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

  2000cited by this paper
• Effects of oral and transdermal 17beta-estradiol with cyclical oral norethindrone acetate on insulin sensitivity, secretion, and elimination in postmenopausal women.

  2000cited by this paper
• Differential expression of estrogen receptor alpha and beta immunoreactivity in the human supraoptic nucleus in relation to sex and aging.

  2000cited by this paper
• Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women.

  2000influential reference
• Hormone Replacement Therapy and Glucose Metabolism

  2000cited by this paper
• Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study.

  1999cited by this paper
• Biological Variation of Glycated Hemoglobin: Implications for diabetes screening and monitoring

  1998cited by this paper
• Hormone replacement therapy, heart disease, and other considerations.

  1998cited by this paper
• Effect of Postmenopausal Hormone Therapy on Glucose and Insulin Concentrations

  1998cited by this paper
• Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus.

  1997cited by this paper
• Age and Sex Effects on HbA1c: A study in a healthy Chinese population

  1997cited by this paper
• Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM

  1997cited by this paper
• Hormone replacement therapy with dydrogesterone and 17β‐oestradiol: effects on serum lipoproteins and glucose tolerance during 24 month follow up

  1997cited by this paper
• Hormone replacement therapy with dydrogesterone and 17 beta-oestradiol: effects on serum lipoproteins and glucose tolerance during 24 month follow up.

  1997cited by this paper
• The effect of postmenopausal estrogen therapy on the risk of non-insulin-dependent diabetes mellitus.

  1997cited by this paper
• Risk of venous thromboembolism in users of hormone replacement therapy.

  1996cited by this paper
• Effect of Aging on HbA1c in a Working Male Japanese Population

  1995cited by this paper
• Sex Differences in Insulin Levels in Older Adults and the Effect of Body Size, Estrogen Replacement Therapy, and Glucose Tolerance Status: The Rancho Bernardo Study, 1984–1987

  1995cited by this paper
• A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women.

  1995cited by this paper
• Sex steroids and lipoprotein metabolism.

  1994cited by this paper
• Sex steroids and lipoprotein metabolism

  1994cited by this paper
• Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy.

  1993cited by this paper
• Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.

  1993cited by this paper
• Association of Hormone-Replacement Therapy With Various Cardiovascular Risk Factors in Postmenopausal Women

  1993cited by this paper
• Effects of low doses of transdermal 17 beta-estradiol on carbohydrate metabolism in postmenopausal women.

  1992cited by this paper
• Ageing and the response of plasma insulin, glucose and C-peptide concentrations to intravenous glucose in postmenopausal women.

  1992cited by this paper
• Postmenopausal estrogen therapy and cardiovascular disease.

  1992cited by this paper
• A prospective study of postmenopausal estrogen therapy and subsequent incidence of non-insulin-dependent diabetes mellitus.

  1992cited by this paper
• Insulin and Cardiovascular Disease: Paris Prospective Study

  1991cited by this paper
• [Postmenopausal estrogen therapy and cardiovascular disease].

  1991cited by this paper
• The variation of endometrial response to a standard hormone replacement therapy in women with premature ovarian failure. An ultrasonographic and histological study

  1991cited by this paper
• Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.

  1991cited by this paper
• Comparison of HbA1 and Fructosamine in Diagnosis of Glucose-Tolerance Abnormalities

  1990cited by this paper
• The relative contributions of age and years since menopause to postmenopausal bone loss.

  1990cited by this paper
• Glycosylation of Proteins: Lack of Influence of Aging

  1988cited by this paper

• Investigating the Effects of Diabetes Mellitus on Several Biochemical Parameters and Histopathological Changes of Some Organs in Rats

  2024cites this paper
• The Effect of 17β-Estradiol Plus Norethisterone Acetate on Estradiol, Testosterone, IGF-1 and SHBG in Postmenopausal Women: A Meta-Analysis of Randomized Controlled Trials

  2024cites this paper
• Deciphering the role of classical oestrogen receptor in insulin resistance and type 2 diabetes mellitus: From molecular mechanism to clinical evidence

  2024cites this paper
• A Comprehensive Review on Diabetes Mellitus and Its Relation to Other Diseases

  2023cites this paper
• The influence of 17β-estradiol plus norethisterone acetate treatment on markers of glucose and insulin metabolism in women: a systematic review and meta-analysis of randomized controlled trials

  2023cites this paper
• Effects of heavy metal, vitamin, and curry consumption on metabolic syndrome during menopause: a Korean community-based cross-sectional study

  2021cites this paper
• Investigating the effects of inorganic nitrate on vascular function, inflammation and platelet reactivity in healthy volunteers and patients with stable angina

  2019cites this paper
• The effect of hormone therapy on bone mineral density and cardiovascular factors among Iranian female athletes with amenorrhea/oligomenorrhea: A randomized clinical trial

  2018cites this paper
• Menopause, hormone therapy and diabetes

  2017cites this paper
• Study the Biochemical Correlation of Insulin Resistance with HbA1c and Sex Hormones in NIDDM Patients/Meisan-Iraq

  2017cites this paper
• Effect of Experimental Diabetes Mellitus on some Biochemical Parameters and Histopathological Changes in Pancreas, Liver, Kidney, and Lung in Ovariectomized Rats

  2016cites this paper
• Can HbA1c Act as a Surrogate Marker for Cardiovascular Risk

  2014cites this paper
• Raloxifene modifies the insulin sensitivity and lipid profile of postmenopausal insulin resistant women

  2013cites this paper
• Évolution de l’HbA 1C en fonction de l’âge et du sexe dans une population française de sujets sans diabète connu âgés de 6 à 79 ans

  2011cites this paper
• [Age and sex variations of HbA(1C) in a French population without known diabetes aged 6 to 79 years].

  2011cites this paper
• Review: Gender Differences in Cardiovascular Disease: Hormonal and Biochemical Influences

  2010cites this paper
• Effect of increasing duration of diabetes mellitus type 2 on glycated hemoglobin and insulin sensitivity

  2006cites this paper
• Correlative study of bone related Biochemical parameters in normal postmenopausal women and hyperglycemic postmenopausal women

  2005cites this paper
• Cardiovascular risk at age 53 years in relation to the menopause transition and use of hormone replacement therapy: a prospective British birth cohort study

  2005cites this paper
• Estrogens, lipoproteins, and cardiovascular risk factors: an update following the randomized placebo-controlled trials of hormone-replacement therapy

  2004cites this paper
• Hormone replacement therapy update: who should we be prescribing this to now?

  2003cites this paper
• Artículo de revisión Menopausia : Nuevas evidencias , nuevos enigmas

  2003cites this paper